about
Historical criteria that distinguish syncope from seizures.Diagnostic criteria for vasovagal syncope based on a quantitative history.Age of first faint in patients with vasovagal syncope.Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.Worsening of symptoms before presentation with vasovagal syncope.Design and use of a quantitative scale for measuring presyncope.Effect of metoprolol on quality of life in the Prevention of Syncope Trial.The development and preliminary validation of a scale measuring the impact of syncope on quality of life.Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia.
P50
Q33147868-B3AAAEB5-FD72-4F71-8B63-66C7A4BFAA3DQ33153167-E61D3814-EB4D-4E6C-B24B-A5582770857DQ33153503-F0F0EACA-FBC9-4501-B9C5-83F1E6A3828FQ33153607-001C95F8-22DA-4B1B-9AB1-F15067E4758EQ33155387-BDA23B76-0E9B-499B-A353-59779FCD6549Q33157292-A5FB7BFE-9770-4D96-89AF-DEE17659A35BQ33157531-67B6871A-B2B7-4A44-8B47-4A3A258C596AQ33157888-A953BD22-0D2A-4671-955E-82C47F6BB4CEQ33158912-FA3CA5EB-913A-455B-8037-2A3536FE458C
P50
description
onderzoeker
@nl
name
Mary-Lou Koshman
@ast
Mary-Lou Koshman
@en
Mary-Lou Koshman
@es
Mary-Lou Koshman
@nl
Mary-Lou Koshman
@sl
type
label
Mary-Lou Koshman
@ast
Mary-Lou Koshman
@en
Mary-Lou Koshman
@es
Mary-Lou Koshman
@nl
Mary-Lou Koshman
@sl
prefLabel
Mary-Lou Koshman
@ast
Mary-Lou Koshman
@en
Mary-Lou Koshman
@es
Mary-Lou Koshman
@nl
Mary-Lou Koshman
@sl